Clinical Trials Browser

Phase 3 × UNKNOWN × nabiximols × Clear all

NCT01262651 2018-04-23

Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer

Phase 3 Completed

397 enrolled 18 charts

Cancer Pain, Pain